Brexpiprazole
| Brexpiprazole | |
|---|---|
| Brexpiprazole.svg | |
| INN | |
| Drug class | |
| Routes of administration | Oral |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 913611-97-9 |
| PubChem | 11978813 |
| DrugBank | DB09128 |
| ChemSpider | 10106341 |
| KEGG | D10300 |
Brexpiprazole is an atypical antipsychotic medication used primarily in the treatment of schizophrenia and as an adjunctive therapy for major depressive disorder. It is marketed under the brand name Rexulti.
Medical uses[edit]
Brexpiprazole is indicated for the treatment of schizophrenia and as an adjunctive treatment for major depressive disorder (MDD). It is also being studied for the treatment of agitation associated with dementia of the Alzheimer's type.
Mechanism of action[edit]
Brexpiprazole acts as a serotonin-dopamine activity modulator (SDAM). It is a partial agonist at 5-HT1A and D2 receptors and an antagonist at 5-HT2A receptors. This unique mechanism of action is thought to contribute to its efficacy in treating both psychotic and mood disorders.
Side effects[edit]
Common side effects of brexpiprazole include weight gain, akathisia, and headache. Less common but more serious side effects can include tardive dyskinesia, neuroleptic malignant syndrome, and hyperglycemia.
Pharmacokinetics[edit]
Brexpiprazole is administered orally. It has a half-life of approximately 91 hours, allowing for once-daily dosing. The drug is metabolized primarily by the cytochrome P450 enzymes CYP3A4 and CYP2D6.
History[edit]
Brexpiprazole was developed by Otsuka Pharmaceutical and Lundbeck. It was approved by the U.S. Food and Drug Administration (FDA) in July 2015 for the treatment of schizophrenia and as an adjunctive treatment for major depressive disorder.
See also[edit]
- Atypical antipsychotic
- Schizophrenia
- Major depressive disorder
- Serotonin-dopamine activity modulator
References[edit]
External links[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Brexpiprazole[edit]
-
Brexpiprazole -
Brexpiprazole molecule ball
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
